Genetics & Getting the Diagnosis Right for ADNP Syndrome

Understanding the genetics of ADNP syndrome (Helsmoortel-Van der Aa syndrome) can be overwhelming, but it is the key to unlocking the “why” behind your child’s diagnosis. At its core, this syndrome is about one vital gene—ADNP—and how a small change in its code affects the entire body.

The Role of the ADNP Gene

Think of the ADNP gene (Activity Dependent Neuroprotective Protein) as a master architect for the brain ^[1][2]. Its job is to manage several critical tasks:

• Chromatin Remodeling: It helps pack and unpack DNA so that other genes can be “read” at the right time during development ^[2][3].
• Microtubule Stability: It acts like a stabilizer for the “skeleton” of brain cells (neurons), helping them grow and branch out correctly ^[4][5].
• Brain Connectivity: It ensures that the brain’s “wiring” (cortical connectivity) is functional and efficient ^[1][3].

In ADNP syndrome, a mutation typically leads to haploinsufficiency ^[6][7]. This means one of the two copies of the gene is not working correctly, often producing a truncated protein—a “shortened” version of the protein that cannot do its job ^[8][1]. Because there isn’t enough functional ADNP protein, the brain’s developmental “blueprints” are disrupted.

What Does ‘De Novo’ Mean?

In the vast majority of cases, ADNP syndrome is caused by a de novo mutation ^[9][10]. This is a Latin term meaning “new” or “from the beginning.”

• Not Inherited: It means the mutation was not passed down from you or your partner ^[9].
• Random Event: The change happened spontaneously in the sperm or egg, or very early in the child’s development ^[9].
• Sibling Risk: Because it is de novo, the chance of having another child with the same condition is generally very low (typically less than 1%), though you should discuss this with a genetic counselor ^[6].

Reading the Genetic Report: The VUS Challenge

Many families begin their diagnostic journey with a test called a Chromosomal Microarray (CMA), which often comes back normal for ADNP syndrome, leading to a frustrating “diagnostic odyssey.” Eventually, most families receive their diagnosis via Whole-Exome Sequencing (WES), a test that “spell-checks” all the protein-coding genes in the body ^[10][7]. However, sometimes the test results are not clear-cut.

If your report says Variant of Uncertain Significance (VUS), it means the lab found a change in the ADNP gene, but they aren’t 100% sure if that specific change causes the syndrome or if it is just a harmless natural variation ^[11][7].

The DNA Methylation Episignature: The “Gold Standard”

To resolve a VUS, doctors can now use a groundbreaking test called a DNA methylation episignature (often called EpiSign) ^[11][7].

• Biological “Fingerprint”: ADNP syndrome leaves a specific chemical mark (methylation) on a person’s DNA ^[11].
• Definitive Confirmation: If the EpiSign test “matches” the known ADNP fingerprint, it confirms the diagnosis, even if the initial genetic report was uncertain ^[11][12].
• Two Types: Scientists have found two distinct patterns (Type 1 and Type 2) depending on where in the gene the mutation is located, though both lead to the same syndrome ^[11][13].

If your child’s diagnosis is still a “maybe” because of a VUS, the EpiSign test is the most powerful tool available to give you a definitive “yes” or “no” ^[11][7]. Obtaining this clarity is an essential step in moving toward the right care and support for your child.

To learn about what treatments and active research studies exist based on your child’s genetic profile, view the Future Outlook & Investigational Therapies page.